Selumetinib CAS 606143-52-6
Selumetinib , Promotion Season Now in Store and Free Sample for Testing with Factory Price
Chemical Name: Selumetinib
CAS No.: 606143-52-6
Molecular Fomula: C17H15BrClFN4O3
Appearance: Beige powder
Selumetinib: The Complete Guide
Request A Free Quote
Description of Selumetinib
Selumetinib (AZD6244) is a drug that was discovered by Array BioPharma and was licensed to AstraZeneca. It is being investigated for the treatment of various types of cancer, such as non-small cell lung cancer (NSCLC).
Basic Info of Selumetinib
Appearance & Physical State
White or pale white solid.
Powder stores in -20ºC directly, which is effective for a period of 2 years.
What is Selumetinib?
With the progress of science and technology and the development of society, chemical products have invariably permeated our daily lives, in medicine, food, cosmetics, electronics, industry, and other areas, becoming an essential part of our lives. One such product is CS-1912 which has developed particularly rapidly in recent years. Do you know about CS-1912?
The official answer:CS-1912, chemically known as 5-[(4-bromo-2-chlorophenyl)amino-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide, was developed by AstraZeneca in the UK for the treatment of advanced non-small cell lung cancer (NSCLC). Its therapeutic mechanism is to inhibit the growth of many tumours including B-Raf-mutated melanoma and K-Ras-mutated non-small cell lung cancer (NSCLC) by regulating the levels of MEK, a key protein kinase in the Ras-Raf-MEK-ERK pathway.
What’s the application of Selumetinib?
The anti-cancer drug selumetinib (CS-1912,1) is developed by AstraZeneca in the UK for the treatment of advanced non-small cell lung cancer (NSCLC). CS-1912 inhibits the growth of a number of tumours, including B-Raf-mutated melanoma and K-Ras-mutated non-small cell lung cancer (NSCLC), by regulating levels of MEK, a key protein kinase in the Ras-Raf-MEK-ERK pathway. It is mainly used for the treatment of cholangiocarcinoma, colorectal cancer and NSCLC. Currently, CS-1912 is in phase III clinical trials for the treatment of non-small cell lung cancer.
Sincere to the customer and in good faith of quality is our forever followed motto. It’s the basement to be a human and do business. We take all responsibility for our products and service sincerely. We are a company integrating R&D, production, and sales. The design, research, and development of pharmaceutical intermediates include more than 330 kinds of pharmaceutical intermediates such as Anti-infectives, Cardiovascular and Cerebrovascular Systems, Digestive systems, Santi-tumor, Nervous systems, Geriatric Drugs, and Gynecological Drugs. At the same time, we have more than 4,000 factories in strategic cooperation with nearly 50,000 chemical products, so we can provide you with a one-stop purchasing service, which greatly saves customers’ procurement costs and time.
Hello, I’m Pew Ni, the chemical products one-stop solution expert.
Hi, I‘m Peter Ni, the founder of Sincere-Chem, I’ve been running a company in China that exporting chemicals, pharmaceuticals, and intermediates for over 70 countries now. And a range of 50,000 products with the best quality and competitive price to meet your different purchasing needs.
CEO Email: email@example.com
CEO Phone Number:
Request A Free Quote
Keywords of Selumetinib
CS-1912, 606143-52-6, buy CS-1912, CS-1912 supplier, purchase CS-1912, CS-1912 cost, CS-1912 manufacturer, order CS-1912, high purity CS-1912